JP2025515165A5 - - Google Patents

Info

Publication number
JP2025515165A5
JP2025515165A5 JP2024565175A JP2024565175A JP2025515165A5 JP 2025515165 A5 JP2025515165 A5 JP 2025515165A5 JP 2024565175 A JP2024565175 A JP 2024565175A JP 2024565175 A JP2024565175 A JP 2024565175A JP 2025515165 A5 JP2025515165 A5 JP 2025515165A5
Authority
JP
Japan
Prior art keywords
factor
polypeptide
modified
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024565175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515165A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066676 external-priority patent/WO2023215879A1/en
Publication of JP2025515165A publication Critical patent/JP2025515165A/ja
Publication of JP2025515165A5 publication Critical patent/JP2025515165A5/ja
Pending legal-status Critical Current

Links

JP2024565175A 2022-05-06 2023-05-05 改変されたＸａ因子ポリペプチドおよび使用方法 Pending JP2025515165A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263339230P 2022-05-06 2022-05-06
US63/339,230 2022-05-06
PCT/US2023/066676 WO2023215879A1 (en) 2022-05-06 2023-05-05 Modified factor xa polypeptides and methods of use

Publications (2)

Publication Number Publication Date
JP2025515165A JP2025515165A (ja) 2025-05-13
JP2025515165A5 true JP2025515165A5 (https=) 2026-04-28

Family

ID=87474126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024565175A Pending JP2025515165A (ja) 2022-05-06 2023-05-05 改変されたＸａ因子ポリペプチドおよび使用方法

Country Status (4)

Country Link
US (1) US20250302927A1 (https=)
EP (1) EP4519431A1 (https=)
JP (1) JP2025515165A (https=)
WO (1) WO2023215879A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021527435A (ja) * 2018-06-19 2021-10-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 第Ｘａ因子阻害剤に対する解毒剤

Similar Documents

Publication Publication Date Title
JP3176604B2 (ja) Ｘａ因子インヒビターおよびそれを含有する医薬組成物
JP2011530599A5 (https=)
JP2023528207A5 (https=)
JP2022552371A5 (https=)
JP2010516290A5 (https=)
JPWO2019156137A5 (https=)
JP2004203890A (ja) マクロファージ炎症蛋白変種
JP2005520834A5 (https=)
KR20060023968A (ko) 중증 급성 호흡기 증후군(ｓａｒｓ)의 치료를 위한 조성물및 방법
JP2024540275A5 (https=)
WO2019213686A1 (en) Therapeutic compositions and uses therefor
JP2023519518A5 (https=)
JP2021532791A5 (https=)
US20240342211A1 (en) Short-term activated dc1s and methods for their production and use
JP2024543209A5 (https=)
JP2022500353A (ja) Ｉｇｆ−１−暗号化ｄｎａ作製物及びｈｇｆ−暗号化ｄｎａ作製物を用いた神経病症治療
JP2022519196A5 (https=)
CN104168910B (zh) 肽及其用途
JP2025515165A5 (https=)
JP2015523861A (ja) 制御された遺伝子発現方法
JP7066409B2 (ja) 癌または転移性疾患の治療または予防における環状アセチルコリンエステラーゼｃ末端ペプチド
KR20230027279A (ko) 화학요법-유발성 독성을 완화하기 위한 내피 세포
JPH04502904A (ja) 両親媒性ペプチドの投与方法およびその組成物
CN113508126A (zh) 新型肽及其用途
WO2000074688A1 (en) Methods for preventing formation of inhibitory antibodies in the setting of gene therapy